Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.643 USD | -1.23% | -14.51% | +88.48% |
May. 09 | Monopar Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 16 | Monopar Therapeutics Files Provisional Patent for New MNPR-101 Construct | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+88.48% | 11.36M | |
+28.66% | 49.18B | |
+0.96% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.38% | 26.09B | |
-22.60% | 18.71B | |
+8.07% | 13.26B | |
+32.17% | 12.32B | |
-0.37% | 11.99B |
- Stock Market
- Equities
- MNPR Stock
- News Monopar Therapeutics Inc.
- Monopar Therapeutics, National University of Singapore Enter Cancer Research Collaboration